USD 0.0
(0.0%)
Year | EBITDA | EBITDA Growth |
---|---|---|
2023 | -707.03 Thousand USD | 43.9% |
2022 | -1.25 Million USD | -3.24% |
2021 | -1.18 Million USD | 37.03% |
2020 | -2.36 Million USD | 0.44% |
2019 | -1.76 Million USD | 34.68% |
2018 | -2.25 Million USD | -45.92% |
2017 | -1.7 Million USD | -14.57% |
2016 | -2.33 Million USD | -17.06% |
2015 | -6.45 Million USD | -6.45% |
2014 | -4.65 Million USD | 41.92% |
2013 | -2.47 Million USD | -585.37% |
2012 | -361.1 Thousand USD | -230.22% |
2011 | -108.89 Thousand USD | -172.25% |
2010 | -43.04 Thousand USD | 0.0% |
Year | EBITDA | EBITDA Growth |
---|---|---|
2023 FY | - USD | 43.9% |
2023 Q1 | - USD | 100.0% |
2023 Q3 | - USD | 0.0% |
2023 Q4 | - USD | 0.0% |
2023 Q2 | - USD | 0.0% |
2022 Q3 | -686.12 Thousand USD | -210.31% |
2022 Q4 | -556.96 Thousand USD | 18.83% |
2022 FY | - USD | -3.24% |
2022 Q1 | -149.19 Thousand USD | 53.17% |
2022 Q2 | -221.11 Thousand USD | -48.2% |
2021 Q4 | -318.58 Thousand USD | -55.83% |
2021 Q2 | -367.9 Thousand USD | -25.65% |
2021 Q1 | -292.79 Thousand USD | 15.75% |
2021 FY | - USD | 37.03% |
2021 Q3 | -204.44 Thousand USD | 44.43% |
2020 Q3 | -848.09 Thousand USD | -105.45% |
2020 Q4 | -347.51 Thousand USD | 59.02% |
2020 FY | - USD | 0.44% |
2020 Q1 | -330.56 Thousand USD | 9.19% |
2020 Q2 | -412.79 Thousand USD | -24.87% |
2019 Q4 | -364 Thousand USD | 28.56% |
2019 Q3 | -509.52 Thousand USD | 7.72% |
2019 FY | - USD | 34.68% |
2019 Q2 | -552.17 Thousand USD | -5.8% |
2019 Q1 | -521.88 Thousand USD | 4.72% |
2018 Q1 | -323.64 Thousand USD | -114.02% |
2018 Q4 | -547.75 Thousand USD | 63.56% |
2018 Q3 | -1.5 Million USD | -147.55% |
2018 Q2 | -607.19 Thousand USD | -87.61% |
2018 FY | - USD | -45.92% |
2017 Q1 | -412.79 Thousand USD | 25.21% |
2017 FY | - USD | -14.57% |
2017 Q2 | -844.24 Thousand USD | -104.52% |
2017 Q3 | -635.16 Thousand USD | 24.76% |
2017 Q4 | -151.21 Thousand USD | 76.19% |
2016 Q4 | -551.94 Thousand USD | -77.76% |
2016 FY | - USD | -17.06% |
2016 Q1 | -509.66 Thousand USD | 50.95% |
2016 Q3 | -310.49 Thousand USD | 15.75% |
2016 Q2 | -368.53 Thousand USD | 27.69% |
2015 Q1 | -416.1 Thousand USD | -2582.13% |
2015 FY | - USD | -6.45% |
2015 Q3 | -457.55 Thousand USD | 46.51% |
2015 Q4 | -1.03 Million USD | -127.11% |
2015 Q2 | -855.33 Thousand USD | -105.56% |
2014 Q2 | -537.42 Thousand USD | -18.75% |
2014 Q1 | -452.56 Thousand USD | 36.97% |
2014 FY | - USD | 41.92% |
2014 Q4 | -15.51 Thousand USD | 96.36% |
2014 Q3 | -425.97 Thousand USD | 20.74% |
2013 Q3 | -376.77 Thousand USD | 58.78% |
2013 Q4 | -717.98 Thousand USD | -90.56% |
2013 FY | - USD | -585.37% |
2013 Q1 | -458.96 Thousand USD | -103.01% |
2013 Q2 | -914.13 Thousand USD | -99.17% |
2012 FY | - USD | -230.22% |
2012 Q1 | -28.41 Thousand USD | -51.46% |
2012 Q2 | -44.44 Thousand USD | -56.41% |
2012 Q3 | -62.17 Thousand USD | -39.9% |
2012 Q4 | -226.07 Thousand USD | -263.64% |
2011 Q4 | -18.75 Thousand USD | -144.04% |
2011 FY | - USD | -172.25% |
2011 Q1 | -37.09 Thousand USD | 0.0% |
2011 Q2 | -45.45 Thousand USD | -22.52% |
2011 Q3 | -7687.00 USD | 83.09% |
2010 FY | - USD | 0.0% |
Name | EBITDA | EBITDA Difference |
---|---|---|
CVR Medical Corp. | - USD | Infinity% |
BioElectronics Corporation | -274.29 Thousand USD | -157.767% |
IR-Med Inc. | -4.89 Million USD | 85.547% |
Polarean Imaging plc | -11.19 Million USD | 93.684% |
Medical Supply International USA, Inc. | 456.06 Thousand USD | 255.03% |
Avitar, Inc. | -1.66 Million USD | 57.607% |
AVITA Medical, Inc. | -39.56 Million USD | 98.213% |
Manhattan Scientifics, Inc. | -1.16 Million USD | 39.259% |
Össur hf. | 137.38 Million USD | 100.515% |
Zecotek Photonics Inc. | -3.44 Million USD | 79.46% |
QHSLab, Inc. | -91.29 Thousand USD | -674.462% |
Wellstar International, Inc. | -1.35 Million USD | 47.879% |
Össur hf. | 137.38 Million USD | 100.515% |
Bionovate Technologies Corp | - USD | Infinity% |
EKF Diagnostics Holdings plc | 9.77 Million USD | 107.234% |
Escalon Medical Corp. | -58.46 Thousand USD | -1109.405% |
Aurora Spine Corporation | -454.37 Thousand USD | -55.604% |
BrainsWay Ltd. | -2.31 Million USD | 69.406% |
Lattice Biologics Ltd. | - USD | Infinity% |
NewCardio, Inc. | -9.37 Million USD | 92.462% |
Hamilton Thorne Ltd. | 5.52 Million USD | 112.805% |
Vivos Inc. | -2.79 Million USD | 74.687% |
MicroPort Scientific Corporation | -347.57 Million USD | 99.797% |
Kelyniam Global, Inc. | -197.69 Thousand USD | -257.644% |
REMSleep Holdings, Inc. | -1.66 Million USD | 57.626% |
CYduct Diagnostics, Inc. | -378.9 Thousand USD | -86.598% |
Nanomix Corporation | -8.13 Million USD | 91.314% |
Theraclion SA | -2.05 Million USD | 65.524% |
Lifeline Biotechnologies, Inc. | - USD | Infinity% |
Positron Corporation | -1.45 Million USD | 51.312% |
Rafina Innovations Inc. | - USD | Infinity% |
Electromedical Technologies, Inc. | -1.72 Million USD | 58.939% |
Lombard Medical, Inc. | -28.06 Million USD | 97.481% |
ALR Technologies Inc. | -6.4 Million USD | 88.953% |
Stratec SE | 39.91 Million USD | 101.771% |
Vycor Medical, Inc. | 100.94 Thousand USD | 800.425% |
Heart Tronics, Inc. | -14.85 Million USD | 95.241% |
Nu-Med Plus, Inc. | -118.25 Thousand USD | -497.866% |
Perimeter Medical Imaging AI, Inc. | -13.27 Million USD | 94.675% |
SANUWAVE Health, Inc. | -9.15 Million USD | 92.275% |
VMS Rehab Systems, Inc. | -68.55 USD | -1031307.732% |
Guided Therapeutics, Inc. | -3.12 Million USD | 77.382% |
Ingen Technologies, Inc. | -8639.00 USD | -8084.165% |
Odyssey Group International, Inc. | -2.13 Million USD | 66.931% |
United American Healthcare Corporation | -59 Thousand USD | -1098.356% |
ECGI Holdings, Inc. | -2.99 Million USD | 76.357% |
Capital Group Holdings, Inc. | -629.18 Thousand USD | -12.373% |
ADM Tronics Unlimited, Inc. | -514.02 Thousand USD | -37.548% |
Urologix, Inc. | -6.34 Million USD | 88.855% |
Rapid Therapeutic Science Laboratories, Inc. | -1.23 Million USD | 42.952% |
Nexeon MedSystems Inc. | -765.96 Thousand USD | 7.694% |
SS Innovations International, Inc. | -20.37 Million USD | 96.53% |
Qualis Innovations, Inc. | -222.81 Thousand USD | -217.313% |
Smith & Nephew plc | 1 Billion USD | 100.071% |
NIOX Group Plc | 11.07 Million USD | 106.384% |
Fuse Medical, Inc. | 1.83 Million USD | 138.524% |
Broncus Holding Corporation | -25.19 Million USD | 97.194% |
Brain Scientific Inc. | -7.93 Million USD | 91.088% |
Pressure BioSciences, Inc. | -9.39 Million USD | 92.471% |
Health Logic Interactive Inc. | -18.4 Thousand USD | -3742.554% |